2016 Emerging Opportunities in the UK Respiratory Diseases Diagnostic Testing Market

October 2015 | 281 pages | ID: 23F0E3DFA45EN
Venture Planning Group

Abstracts

About this Report

This new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for microbiology testing;
• Profiles key suppliers and potential market entrants developing innovative technologies and products; and
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 281 pages and 21 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Adenovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
  2. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. Mycoplasma
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  7. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. Tuberculosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
U.K. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Influenza Testing Market Diagnostics Sales by Major Supplier
U.K. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. RSV Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier